Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016 (2016), Article ID 3476143, 3 pages
http://dx.doi.org/10.1155/2016/3476143
Case Report

Inflammatory Breast Cancer from Metastatic Ovarian Cancer

1Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Bangkok 10700, Thailand
2Department of Pathology, Faculty of Medicine Siriraj Hospital, Bangkok 10700, Thailand

Received 18 December 2015; Revised 13 February 2016; Accepted 16 February 2016

Academic Editor: Giampiero Capobianco

Copyright © 2016 Vuthinun Achariyapota et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. I. Hajdu and J. A. Urban, “Cancers metastatic to the breast,” Cancer, vol. 29, no. 6, pp. 1691–1696, 1972. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Recine, M. T. Deavers, L. P. Middleton, E. G. Silva, and A. Malpica, “Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall,” American Journal of Surgical Pathology, vol. 28, no. 12, pp. 1646–1651, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. L. Klein, A. R. Brown, C. M. Gomez-Castro et al., “Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review,” Journal of Cancer, vol. 1, no. 1, pp. 27–31, 2010. View at Google Scholar · View at Scopus
  4. T. Sato, I. Muto, M. Fushiki et al., “Metastatic breast cancer from gastric and ovarian cancer, mimicking inflammatory breast cancer: report of two cases,” Breast Cancer, vol. 15, no. 4, pp. 315–320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Tornos, R. Soslow, S. Chen et al., “Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary,” American Journal of Surgical Pathology, vol. 29, no. 11, pp. 1482–1489, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Y. Chen, “Immunostain update: diagnosis of metastatic breast carcinoma, emphasizing the distinction from gynecologic cancers,” June 2010, http://nulldownload.com/doc/pdf/immunostain-update-diagnosis-of-metastatic-breast.html.
  7. Y. Wang, Y. Wang, J. Li et al., “PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy,” Journal of Hematology and Oncology, vol. 6, article 60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Gown, R. S. Fulton, and P. L. Kandalaft, “Markers of metastatic carcinoma of breast origin,” Histopathology, vol. 68, no. 1, pp. 86–95, 2016. View at Publisher · View at Google Scholar